Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
144M
-
Number of holders
-
208
-
Total 13F shares, excl. options
-
128M
-
Shares change
-
+1.34M
-
Total reported value, excl. options
-
$1.79B
-
Value change
-
+$17M
-
Put/Call ratio
-
0.55
-
Number of buys
-
129
-
Number of sells
-
-86
-
Price
-
$14.01
Significant Holders of MARAVAI LIFESCIENCES HOLDINGS, INC. - Common Stock (MRVI) as of Q1 2023
249 filings reported holding MRVI - MARAVAI LIFESCIENCES HOLDINGS, INC. - Common Stock as of Q1 2023.
MARAVAI LIFESCIENCES HOLDINGS, INC. - Common Stock (MRVI) has 208 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 128M shares
of 144M outstanding shares and own 88.79% of the company stock.
Largest 10 shareholders include GTCR LLC (21.7M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (11.8M shares), VANGUARD GROUP INC (10.6M shares), Thrivent Financial for Lutherans (8.19M shares), BlackRock Inc. (5.9M shares), JPMORGAN CHASE & CO (3.89M shares), Ownership Capital B.V. (3.8M shares), Clearbridge Investments, LLC (3.24M shares), RENAISSANCE TECHNOLOGIES LLC (3.19M shares), and 12 West Capital Management LP (2.57M shares).
This table shows the top 208 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.